Evidence map›Paper›PMID 26640775›Full record

ArticleJournal of global antimicrobial resistance2015

A computational model to monitor and predict trends in bacterial resistance.

Ali Alawieh, Zahraa Sabra, Abdul Rahman Bizri, Christopher Davies, Roger White, Fadi A Zaraket

Abstract read
In one paragraph

Article in Journal of global antimicrobial resistance, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali Alawieh *Neuroscience Institute, Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Zahraa Sabra *Department of Electrical and Computer Engineering, American University of Beirut, Beirut, Lebanon.
Abdul Rahman BizriDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Christopher DaviesDepartment of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Roger WhiteDepartment of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Fadi A ZaraketDepartment of Electrical and Computer Engineering, American University of Beirut, Beirut, Lebanon.

Funding

Supplement to Molecular Targets in Peptidoglycan SynthesisR01GM066861 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DAVIES, CHRISTOPHER · 2003 to 2019
$5.4M
NIGMS NIH HHS R01 GM066861
6 · The paper itself

Abstract

Current concern over the emergence of multidrug-resistant superbugs has renewed interest in approaches that can monitor existing trends in bacterial resistance and make predictions of future trends. Recent advances in bacterial surveillance and the development of online repositories of susceptibility tests across wide geographical areas provide an important new resource, yet there are only limited computational tools for its exploitation. Here we propose a hybrid computational model called BARDmaps for automated analysis of antibacterial susceptibility tests from surveillance records and for performing future predictions. BARDmaps was designed to include a structural computational model that can detect patterns among bacterial resistance changes as well as a behavioural computational model that can use the detected patterns to predict future changes in bacterial resistance. Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) were used to validate and apply the model. BARDmaps was compared with standard curve-fitting approaches used in epidemiological research. Here we show that BARDmaps can reliably predict future trends in bacterial resistance across Europe. BARDmaps performed better than other curve-fitting approaches for predicting future resistance levels. In addition, BARDmaps was also able to detect abrupt changes in bacterial resistance in response to outbreaks and interventions as well as to compare bacterial behaviour across countries and drugs. In conclusion, BARDmaps is a reliable tool to automatically predict and analyse changes in bacterial resistance across Europe. We anticipate that BARDmaps will become an invaluable tool both for clinical providers and governmental agencies to help combat the threat posed by antibiotic-resistant bacteria.

Indexed as

Antimicrobial resistanceComputational modellingResistance monitoring

Identifiers

PMID26640775
PMCPMC4666607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.